You may have come into close contact with (NYSE: MDT) if you've undergone a medical procedure. The company makes devices used in endoscopy, spine surgery, cardiovascular diagnostics -- and more. In fact, Medtronic is such huge player that the company won clearance for 125 products in the past 12 months. 

That didn't help stock performance last year. The stock sank in the double digits. Medtronic's big problem has been growth -- but things may be picking up. The company is making progress in its plan to boost growth -- and investors are taking notice. The shares have gained about 12% since the start of this year. Should you buy the device giant? Let's look at one green flag and one red flag before deciding.

Medtronic could become a major force in a very hot growth area. And that's artificial intelligence (AI). The company already has invested in AI and developed products that are changing the world of medicine.

Continue reading

Source Fool.com